34 results
S-4/A
EX-99.4
ADAP
Adaptimmune Therapeutics Plc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
and browse skills Search “Vote my Proxy” Enable skill TO ATTEND the Special Meeting, please visit www.proxydocs.com/TCRR for virtual meeting
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
27 Oct 16
Adaptimmune Announces Board Changes
12:00am
, including his healthcare experience, will complement the skills and expertise of our other Board members.”
“I am very pleased and excited to join
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
-independent TCR (“HiT”) platform. It brings together highly complementary skills and expertise across the two organizations, and will enable
8-K
EX-10.4
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, diligently and to a standard commensurate with the functions of your role and your knowledge, skills and experience.
You shall exercise your powers in your … and, where necessary, removing senior management and in succession planning;
devote time to developing and refreshing your knowledge and skills;
uphold
8-K
EX-99.1
qg9zb3auo8k 1chrzb
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.3
xhku osim
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
dxgpy0c6
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.2
ztucj
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
10-K
EX-10.17
844c 1hva
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
drwlpdo8bwt
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am